Wall Street Experts
| Wartość aktywów (mln USD): | 611 | |||||||||||
| Liczba spółek: | 26 | |||||||||||
| Stopa dywidendy: | - % | |||||||||||
| Opłata za zarządzanie:: | 0.36 % | |||||||||||
| Klasa aktywów: | Equity |
ISIN: US92189F6925
Wystawca ETF: VanEck| Nazwa | Symbol | Klasa_aktywów | Wartość_aktywów | 5D | 1M | 3M | 6M | 2024 | 1R | 3L | 5L | 10L |
|---|
| Sektor | Udział % |
|---|---|
| Technologie Medyczne | 86.1 |
| Usługi Dystrybucyjne | 13.9 |
| Gotówka | 0.0 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | 73 110 766 | 11.5 | 92 652 |
| Johnson & Johnson | JNJ | 41 365 411 | 6.5 | 258 825 |
| Abbvie Inc | ABBV | 41 249 091 | 6.5 | 204 568 |
| Novartis Ag | NVS | 33 410 933 | 5.3 | 297 621 |
| Cencora Inc | COR | 33 152 553 | 5.2 | 114 572 |
| Mckesson Corp | MCK | 32 560 092 | 5.1 | 45 416 |
| Astrazeneca Plc | AZN | 31 628 150 | 5.0 | 427 870 |
| Sanofi Sa/France | SNY | 30 613 909 | 4.8 | 560 489 |
| Merck & Co Inc | MRK | 29 922 990 | 4.7 | 346 371 |
| Haleon Plc | HLN | 29 843 371 | 4.7 | 2 855 825 |
| Takeda Pharmaceutical Co Ltd | TAK | 29 607 725 | 4.7 | 1 949 159 |
| Gsk Plc | GSK | 29 198 009 | 4.6 | 748 475 |
| Novo Nordisk A/S | NVO | 29 009 812 | 4.6 | 432 337 |
| Zoetis Inc | ZTS | 28 729 001 | 4.5 | 179 995 |
| Bristol-Myers Squibb Co | BMY | 27 830 602 | 4.4 | 486 549 |
| Pfizer Inc | PFE | 27 493 729 | 4.3 | 1 131 895 |
| Teva Pharmaceutical Industries Ltd | TEVA | 26 222 530 | 4.1 | 1 765 827 |
| Viatris Inc | VTRS | 13 946 941 | 2.2 | 1 709 184 |
| Jazz Pharmaceuticals Plc | JAZZ | 12 006 729 | 1.9 | 99 377 |
| Axsome Therapeutics Inc | AXSM | 6 565 645 | 1.0 | 60 855 |
| Elanco Animal Health Inc | ELAN | 6 195 450 | 1.0 | 637 392 |
| Organon & Co | OGN | 5 794 522 | 0.9 | 401 005 |
| Perrigo Co Plc | PRGO | 5 556 437 | 0.9 | 206 559 |
| Patterson Cos Inc | PDCO | 3 671 450 | 0.6 | 117 637 |
| Other/Cash | 2 902 010 | 0.5 | 0 | |
| Bausch Health Cos Inc | BHC | 2 558 683 | 0.4 | 451 267 |